Autoantibodies to the extracellular matrix microfibrillar protein, fibrillin-1, in patients with scleroderma and other connective tissue diseases

FK Tan, FC Arnett, S Antohi, S Saito… - The Journal of …, 1999 - journals.aai.org
FK Tan, FC Arnett, S Antohi, S Saito, A Mirarchi, H Spiera, T Sasaki, O Shoichi, K Takeuchi…
The Journal of Immunology, 1999journals.aai.org
A duplication in the fibrillin-1 gene has been implicated as the cause of the tight skin 1 (tsk1)
phenotype, an animal model of scleroderma or systemic sclerosis (SSc). In addition to the
production of abnormal fibrillin-1 protein, the tsk1 mouse also produces autoantibodies to
fibrillin-1. Among a population of Choctaw Native Americans with the highest prevalence of
SSc yet described, a chromosome 15q haplotype containing the fibrillin-1 gene has been
strongly associated with SSc. With a recombinant human fibrillin-1 protein, autoantibodies to …
Abstract
A duplication in the fibrillin-1 gene has been implicated as the cause of the tight skin 1 (tsk1) phenotype, an animal model of scleroderma or systemic sclerosis (SSc). In addition to the production of abnormal fibrillin-1 protein, the tsk1 mouse also produces autoantibodies to fibrillin-1. Among a population of Choctaw Native Americans with the highest prevalence of SSc yet described, a chromosome 15q haplotype containing the fibrillin-1 gene has been strongly associated with SSc. With a recombinant human fibrillin-1 protein, autoantibodies to fibrillin-1 were detected in the sera of Native American SSc patients that correlated significantly with disease. Abs to fibrillin-1 also were detected in sera from Japanese, Caucasian, and African-American SSc patients. Compared with other ethnic groups, Japanese and Native American SSc patients had significantly higher frequencies of anti-fibrillin-1 Abs. Sera from patients with diffuse SSc, calcinosis, Raynaud’s, esophageal dysmotility, sclerodactyly, and telangiectasias syndrome and mixed connective tissue disease also had significantly higher frequencies of anti-fibrillin-1 Abs than sera from controls or patients with other non-SSc connective tissue diseases (lupus, rheumatoid arthritis, and Sjögren’s syndrome). Ab specificity for fibrillin-1 was demonstrated by the lack of binding to a panel of other purified autoantigens. The results presented demonstrate for the first time the presence of high levels of anti-fibrillin-1 Abs in a significant portion of patients with SSc.
journals.aai.org